MPC-3100 has been completed in phase I clinical trials for the treatment of refractory or relapsed cancer.

June 21, 2017

prudect name : MPC-3100 has been completed in phase I clinical trials for the treatment of refractory or relapsed cancer.
MPC-3100

Synonyms: CAS NO: 958025-66-6Molecular Formula: C₂₂H₂₅BrN₆O₄SMolecular Weight: 549.44Purity: 98% minSolubility: In DMSOStorage: -20°C